Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Multicenter Study Comparing the Safety and Efficacy of Oral Febuxostat Versus Allopurinol in Subjects With Gout

NCT00102440 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00102440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00102440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Multicenter Study Comparing the Safety and Efficacy of Oral Febuxostat Versus Allopurinol in Subjects With Gout
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2002
Completion date
February 29, 2004
Enrollment
760 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gout